• Explore /
  • Poster
  • / A multi-institutional, single-arm, phase II trial of neoadjuvant modified-FOLFIRINOX for resectable pancreatic ductal adenocarcinoma.

A multi-institutional, single-arm, phase II trial of neoadjuvant modified-FOLFIRINOX for resectable pancreatic ductal adenocarcinoma.

Abstract Poster

Authors

null

Choong-kun Lee

Division of Medical Oncology, Yonsei Cancer Center, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea;

Choong-kun Lee , Ho Kyoung Hwang , Hei-Cheul Jeung , Hongjae Chon , Hyung Soon Park , Min Hwan Kim , Sung Hyun Kim , Mi-Suk Park , Chang Moo Kang , Hye Jin Choi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05066802

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 715)

DOI

10.1200/JCO.2023.41.4_suppl.715

Abstract #

715

Poster Bd #

L2

Abstract Disclosures

Similar Posters

Poster

2022 ASCO Gastrointestinal Cancers Symposium

A multi-institutional, single-arm, phase II trial of neoadjuvant modified-FOLFIRINOX for resectable pancreatic ductal adenocarcinoma.

A multi-institutional, single-arm, phase II trial of neoadjuvant modified-FOLFIRINOX for resectable pancreatic ductal adenocarcinoma.

First Author: Choong-kun Lee

First Author: Sherise C. Rogers

First Author: Sherise C. Rogers

First Author: Thomas J. George